Stocks to buy

The concept of best climate change stocks to buy for 2023 presents a critically ethical tone. According to multiple scientists and investigative reports, human-caused environmental impact imposed many negative developments on our planet. To mitigate and hopefully reverse the consequences of prior activities, we must start taking action now. Unfortunately, a perception exists that even
0 Comments
Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL) is expected to disclose its fourth-quarter 2022 financial results after the market closes on Feb. 2. As that date approaches, many investors are feeling anxious about GOOG stock. Yet, bona fide contrarians should use that anxiety to their advantage, as fear and muted expectations could lead to a positive surprise. The same FAANG
0 Comments
Healthcare stocks performed well in 2022, driven by a number of factors. One of the main drivers was the ongoing COVID-19 pandemic, which continued to boost demand for healthcare products and services. That substantial success last year is leading investors to search for healthcare stocks that will be big winners in 2023. The pandemic drove significant
0 Comments
CRISPR technology has the potential to revolutionize the way we approach medicine. This technology has already been used in a variety of applications, including gene editing, gene therapy, and disease diagnosis. As a result, companies developing CRISPR-based products and services have seen significant valuation growth since inception, with many CRISPR stocks having excellent long-term upside
0 Comments
Discussing undervalued retirement stocks usually brings defensive stocks to mind, especially those with high dividends and low exposure to market volatility. While defensive stocks are great for your retirement portfolio, you should also add some growth potential, especially if you aren’t already a retiree. Things have shifted due to market volatility and recent selloffs, and
0 Comments
As much as we may recognize that short sellers perform a valuable service for the equities market, the concept of targeting short-squeeze stocks to buy just to penalize the pessimists carries cathartic value. Fundamentally, market bears operate like great white sharks. As loathsome and fearsome as these creatures may be, they eliminate weak or sick
0 Comments
One of the secondary consequences of Russia’s invasion of Ukraine was the impact of environmental, social, and governance (ESG) initiatives, negatively affecting even the most highly rated ESG companies. Essentially, the war sparked immediate demand for weaponry, resulting in poor outcomes for the environment. However, unprecedented support for Ukraine may also undergird international policymakers’ hopes
0 Comments
Almost three years ago today, the mysterious SARS-CoV-2 virus began spreading across the globe, utterly guaranteeing the destruction of travel stocks to buy. Indeed, airports became veritable ghost towns as few people wanted to be stuck in a flying tube with strangers. Fortunately, with the distribution of Covid-19 vaccines, society everywhere began gradually normalizing. Moving
0 Comments
When markets witness extreme reactions, individual stocks can be overvalued or undervalued. However, in most cases, well-known stocks already have discounted news in the price. That’s the efficient market hypothesis. Having said that, there are little-known stocks in the universe of stocks that are flying under the radar. With limited investor interest and institutional holding,
0 Comments
In recent weeks, the Street has become much more enamored with pharma stocks than it was previously. The iShares Biotechnology ETF (NASDAQ:IBB) climbed 6% so far this year. As a result, those who invest in pharma stocks now will benefit from the sector’s current positive momentum. But from my perspective, that’s just icing on the
0 Comments